#ESCCongress – [Abstract Only] Randomized trial: Colchicine in patients with chronic coronary disease

Colchicine in Patients with Chronic Coronary Disease – New England Journal of Medicine

Commentaries: LoDoCo2: Colchicine Protective in Large RCT of Chronic Coronary Disease – TCTMD AND Low Dose Colchicine for Secondary Prevention of Cardiovascular Disease 2 – LoDoCo2 – American College of Cardiology

Commentary on Twitter

Patients with chronic coronary disease were randomized to daily colchicine or placebo. Incidence of the composite endpoint of cardiovascular death, spontaneous MI, ischemic stroke, or ischemia-driven coronary revascularization was significantly lower with colchicine. #ESCCongress

— NEJM (@NEJM) August 31, 2020